Mayne Pharma Group Ltd (MAYNF)
3.265
0.00 (0.00%)
USD |
OTCM |
Jun 14, 16:00
Mayne Pharma Group Enterprise Value: 197.21M for June 14, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
June 14, 2024 | 197.21M |
June 13, 2024 | 197.21M |
June 12, 2024 | 197.21M |
June 11, 2024 | 197.21M |
June 10, 2024 | 197.21M |
June 07, 2024 | 197.21M |
June 06, 2024 | 197.21M |
June 05, 2024 | 197.21M |
June 04, 2024 | 203.17M |
June 03, 2024 | 203.17M |
May 31, 2024 | 203.17M |
May 30, 2024 | 203.17M |
May 29, 2024 | 281.86M |
May 28, 2024 | 281.86M |
May 24, 2024 | 281.86M |
May 23, 2024 | 281.86M |
May 22, 2024 | 281.86M |
May 21, 2024 | 281.86M |
May 20, 2024 | 281.86M |
May 17, 2024 | 281.86M |
May 16, 2024 | 300.58M |
May 15, 2024 | 300.58M |
May 14, 2024 | 300.58M |
May 13, 2024 | 300.58M |
May 10, 2024 | 300.58M |
Date | Value |
---|---|
May 09, 2024 | 298.88M |
May 08, 2024 | 298.88M |
May 07, 2024 | 298.88M |
May 06, 2024 | 298.88M |
May 03, 2024 | 298.88M |
May 02, 2024 | 298.88M |
May 01, 2024 | 298.88M |
April 30, 2024 | 298.88M |
April 29, 2024 | 298.88M |
April 26, 2024 | 298.88M |
April 25, 2024 | 298.88M |
April 24, 2024 | 305.68M |
April 23, 2024 | 305.68M |
April 22, 2024 | 305.68M |
April 19, 2024 | 299.73M |
April 18, 2024 | 299.73M |
April 17, 2024 | 299.73M |
April 16, 2024 | 299.73M |
April 15, 2024 | 299.73M |
April 12, 2024 | 299.73M |
April 11, 2024 | 299.73M |
April 10, 2024 | 299.73M |
April 09, 2024 | 299.73M |
April 08, 2024 | 282.61M |
April 05, 2024 | 282.61M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
38.79M
Minimum
Oct 04 2023
860.42M
Maximum
Oct 08 2019
490.42M
Average
554.97M
Median
Enterprise Value Benchmarks
Alterity Therapeutics Ltd | -- |
Kazia Therapeutics Ltd | 3.883M |
Immutep Ltd | -- |
Opthea Ltd | 4.905M |
Mesoblast Ltd | -- |
Enterprise Value Related Metrics
Earnings Yield | -60.67% |
Normalized Earnings Yield | -54.65 |